Recombinant multi-species STAT6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STAT6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein plays a central role in exerting IL4 mediated biological responses. It is found to induce the expression of BCL2L1/BCL-X(L), which is responsible for the anti-apoptotic activity of IL4. Knockout studies in mice suggested the roles of this gene in differentiation of T helper 2 (Th2) cells, expression of cell surface markers, and class switch of immunoglobulins. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
The Alternative Names of target: D12S1644,HIES6,IL-4 Stat,IL-4-STAT,STAT6,STAT6B,STAT6C,Signal transducer and activator of transcription 6,Stat6

Target products collectionGo to STAT6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T20585-Ag-1/ GM-Tg-hg-T20585-Ag-2 Human STAT6 protein Human
GM-Tg-rg-T20585-Ag-1/ GM-Tg-rg-T20585-Ag-2 Rat STAT6 protein Rat
GM-Tg-mg-T20585-Ag-1/ GM-Tg-mg-T20585-Ag-2 Mouse STAT6 protein Mouse
GM-Tg-cynog-T20585-Ag-1/ GM-Tg-cynog-T20585-Ag-2 Cynomolgus/Rhesus macaque STAT6 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T20585-Ag-1/ GM-Tg-felg-T20585-Ag-2 Feline STAT6 protein Feline
GM-Tg-cang-T20585-Ag-1/ GM-Tg-cang-T20585-Ag-2 Canine STAT6 protein Canine
GM-Tg-bovg-T20585-Ag-1/ GM-Tg-bovg-T20585-Ag-2 Bovine STAT6 protein Bovine
GM-Tg-equg-T20585-Ag-1/ GM-Tg-equg-T20585-Ag-2 Equine STAT6 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T20585-Ag-1/ GM-Tg-hg-T20585-Ag-2; GM-Tg-rg-T20585-Ag-1/ GM-Tg-rg-T20585-Ag-2;
GM-Tg-mg-T20585-Ag-1/ GM-Tg-mg-T20585-Ag-2; GM-Tg-cynog-T20585-Ag-1/ GM-Tg-cynog-T20585-Ag-2;
GM-Tg-felg-T20585-Ag-1/ GM-Tg-felg-T20585-Ag-2; GM-Tg-cang-T20585-Ag-1/ GM-Tg-cang-T20585-Ag-2;
GM-Tg-bovg-T20585-Ag-1/ GM-Tg-bovg-T20585-Ag-2; GM-Tg-equg-T20585-Ag-1/ GM-Tg-equg-T20585-Ag-2
Products Name STAT6 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name STAT6
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STAT6 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.